GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genovis AB (OSTO:GENO) » Definitions » Cash Flow from Discontinued Operations

Genovis AB (OSTO:GENO) Cash Flow from Discontinued Operations : kr0.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Genovis AB Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Genovis AB's cash flow from discontinued operations for the three months ended in Sep. 2024 was kr0.0 Mil. It means Genovis AB received kr0.0 Mil from the sale of part of business quarterly. Genovis AB's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Sep. 2024 was kr0.0 Mil.

Genovis AB Cash Flow from Discontinued Operations Historical Data

The historical data trend for Genovis AB's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genovis AB Cash Flow from Discontinued Operations Chart

Genovis AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Discontinued Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Genovis AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Genovis AB Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genovis AB Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Genovis AB's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Genovis AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genovis AB (OSTO:GENO) » Definitions » Cash Flow from Discontinued Operations
Comparable Companies
OSTO:XSPRAY OSTO:DMYD B OSTO:VICO OSTO:SANION OSTO:IBT B OSTO:ABLI OSTO:EGTX OSTO:MAGLE OSTO:BINV XSAT:HAMLET B VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
5GV:Germany
Address
Scheelevagen 2, Box 790, Lund, SWE, SE-220 07
Website
https://www.genovis.com
Genovis AB provides enzymes and technologies for the analytical characterization and conjugation of biopharmaceuticals. The principal activities of the company are to develop, produce, and market tools for developing new drugs and diagnostics. Its product line comprises GingisREX, FabRICATOR, GlyCLICK, GingisKHAN, GlycINATOR, Fabulous, lgGZERO, and Enzymes for O-glycan. The company's main product category consists of Enzymes and Antibodies. Geographically its segments include Sweden and the rest of the world.

Genovis AB Headlines

No Headlines